help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warshamana, G. S.
Right arrow Articles by Brody, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warshamana, G. S.
Right arrow Articles by Brody, A. R.
American Journal of Respiratory Cell and Molecular Biology. Vol. 27, pp. 705-713, 2002
© 2002 American Thoracic Society
DOI: 10.1165/rcmb.2002-0096OC

Susceptibility to Asbestos-Induced and Transforming Growth Factor-ß1–Induced Fibroproliferative Lung Disease in Two Strains of Mice

G. Sakuntala Warshamana, Derek A. Pociask, Patricia Sime, David A. Schwartz and Arnold R. Brody

Lung Biology Program, Department of Pathology, Tulane University Health Sciences Center, New Orleans, Louisiana; Department of Medicine, University of Rochester, Rochester, New York; and Duke University Medical Center, Department of Medicine, Durham, North Carolina

Address correspondence to: Arnold R. Brody, Ph.D., Department of Pathology, Tulane University Health Sciences Center, 1430 Tulane Avenue, SL-79, New Orleans, LA 70112-2699. E-mail: abrody{at}tulane.edu

Pulmonary fibrosis (PF) is caused by a number of inhaled agents, as well as by some drugs and toxic particles. The elaboration of certain peptide growth factors is thought to be key to the development of this disease process. In addition, genetic susceptibility plays a role in the development of PF. For instance, we have previously shown that the 129J strain of mice is resistant, whereas the C57BL/6 strain is highly susceptible, to asbestos-induced fibrosis. To pursue this further, in one mouse model, we crossed the 129J strain to the C57BL/6 strain to produce an F1 generation and subsequently backcrossed the F1 mice to the inbred founders. This backcross to the 129 inbred strain produced {bsim} 25% of the offspring with a phenotype that was protected from the fibrogenic effects of inhaled asbestos fibers. In the second model, both strains of mice were treated intratracheally with an adenovirus vector (AdV), which transduces expression of active transforming growth factor (TGF)-ß1 in the lungs, producing fibroproliferative lung disease. Compared with C57 mice, a significant number of 129 strain mice exhibited at least a 1-wk delay in the fibroproliferative response to TGF-ß1 expression at three concentrations of virus. These findings suggest that certain sequences in a gene or a cluster of genes in the 129 mouse strain impart a phenotype in which there is a delay in, or protection from, the development of lung fibrogenesis.

Abbreviations: adenovirus, AdV • bronchoalveolar lavage, BAL • Bromodeoxyuridine, BrdU • enzyme-linked immunosorbent assay, ELISA • hematoxylin and eosin, H&E • idiopathic pulmonary fibrosis, IPF • phosphate-buffered saline, PBS • platelet-derived growth factor, PDGF • pulmonary fibrosis, PF • plaque-forming units, pfu • transforming growth factor, TGF • tumor necrosis factor, TNF




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
D. A. Schwartz
Genetic Analysis of Sporadic and Familial Interstitial Pneumonia
Proceedings of the ATS, April 15, 2008; 5(3): 343 - 347.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. V. Yang, L. H. Burch, M. P. Steele, J. D. Savov, J. W. Hollingsworth, E. McElvania-Tekippe, K. G. Berman, M. C. Speer, T. A. Sporn, K. K. Brown, et al.
Gene Expression Profiling of Familial and Sporadic Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 45 - 54.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. P. Steele, M. C. Speer, J. E. Loyd, K. K. Brown, A. Herron, S. H. Slifer, L. H. Burch, M. M. Wahidi, J. A. Phillips III, T. A. Sporn, et al.
Clinical and Pathologic Features of Familial Interstitial Pneumonia
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1146 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
K. A. Keogh, J. Standing, G. C. Kane, A. Terzic, and A. H. Limper
Angiotensin II antagonism fails to ameliorate bleomycin-induced pulmonary fibrosis in mice
Eur. Respir. J., April 1, 2005; 25(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. Bonniaud, G. Martin, P. J. Margetts, K. Ask, J. Robertson, J. Gauldie, and M. Kolb
Connective Tissue Growth Factor Is Crucial to Inducing a Profibrotic Environment in "Fibrosis-Resistant" Balb/c Mouse Lungs
Am. J. Respir. Cell Mol. Biol., November 1, 2004; 31(5): 510 - 516.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
I. Kalomenidis, K. Lane, T. S. Blackwell, Y. Guo, and R. W. Light
Mice Are Resistant to the Induction of a Pleurodesis
Chest, December 1, 2003; 124(6): 2407 - 2408.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. Dai, C. Xie, R. Vincent, and A. Churg
Air Pollution Particles Produce Airway Wall Remodeling in Rat Tracheal Explants
Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 352 - 358.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2002 American Thoracic Society.
  CCM abstracts